BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//INDUNIV | Industry University Research Center, Inc. - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.induniv.org
X-WR-CALDESC:Events for INDUNIV | Industry University Research Center, Inc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260311T080000
DTEND;TZID=UTC:20260312T170000
DTSTAMP:20261021T234442
CREATED:20261007T221903Z
LAST-MODIFIED:20261014T160032Z
UID:4819-1773216000-1773334800@www.induniv.org
SUMMARY:Bio On the Road visits Puerto Rico\, the top pharma manufacturer
DESCRIPTION:Puerto Rico\, which hosts more biotech manufacturing than any state in the Union\, is positioning itself to lead in reshoring\, a BIO delegation learned last week.What happened: BIO President & CEO John F. Crowley led a March 11-12 BIO on the American Road tour of Puerto Rico’s biotech ecosystem.Why it matters: “We have the greatest density of pharmaceutical and medical device companies in the world\,” said Ivan Lugo\, ED of INDUNIV\, BIO’s affiliate in Puerto Rico. The territory leads U.S. pharma exports\, at $54+ billion annually.Reshoring: Puerto Rico is “playing aggressively” to reshore manufacturing\, said PR Development Secretary Sebastián Negrón Reichard. Recently\, Eli Lilly announced a $1.2 billion expansion in their Carolina\, PR facility\, and Amgen announced a $650 million expansion at their Juncos\, PR pharma plant\, the largest on the island.Amgen’s investment reflects “the company’s long-standing commitment to U.S. biomanufacturing and global supply chain resilience\, and underscores confidence in Puerto Rico’s skilled workforce and infrastructure\,” said Thomas Seewoester\, Amgen VP and Site Head.Academia and research: University of Puerto Rico “is proud to contribute to the advancement of biotechnology” with a research center and skilled workers\, said UPR President Zayira Jordán-Conde. The PR Science\, Technology & Research Trust presented its biotech incubator and clinical trial center. “Patients are at the center of our clinical research strategy\,” said Luz A. Crespo\, CEO.BIO’s view: “Through sustained investments in workforce development\, cutting-edge research infrastructure\, and strong partnerships between industry\, academia\, and government\, Puerto Rico is positioning itself as one of the most dynamic biotech ecosystems in the United States\,” Crowley said.Read more on Bio.News.
URL:https://www.induniv.org/event/bio-on-the-road-visits-puerto-rico-the-top-pharma-manufacturer/
ATTACH;FMTTYPE=image/jpeg:https://www.induniv.org/wp-content/uploads/2025/10/events-thumb_on-the-american-road.jpg
END:VEVENT
END:VCALENDAR